143 related articles for article (PubMed ID: 33247991)
1. Angiopoietin-like protein 4 deficiency augments liver fibrosis in liver diseases such as nonalcoholic steatohepatitis in mice through enhanced free cholesterol accumulation in hepatic stellate cells.
Teratani T; Tomita K; Wada A; Sugihara N; Higashiyama M; Inaba K; Horiuchi K; Hanawa Y; Nishii S; Mizoguchi A; Tanemoto R; Ito S; Okada Y; Kurihara C; Akita Y; Narimatsu K; Watanabe C; Komoto S; Oike Y; Miura S; Hokari R; Kanai T
Hepatol Res; 2021 May; 51(5):580-592. PubMed ID: 33247991
[TBL] [Abstract][Full Text] [Related]
2. Free cholesterol accumulation in hepatic stellate cells: mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice.
Tomita K; Teratani T; Suzuki T; Shimizu M; Sato H; Narimatsu K; Okada Y; Kurihara C; Irie R; Yokoyama H; Shimamura K; Usui S; Ebinuma H; Saito H; Watanabe C; Komoto S; Kawaguchi A; Nagao S; Sugiyama K; Hokari R; Kanai T; Miura S; Hibi T
Hepatology; 2014 Jan; 59(1):154-69. PubMed ID: 23832448
[TBL] [Abstract][Full Text] [Related]
3. Acyl-CoA:cholesterol acyltransferase 1 mediates liver fibrosis by regulating free cholesterol accumulation in hepatic stellate cells.
Tomita K; Teratani T; Suzuki T; Shimizu M; Sato H; Narimatsu K; Usui S; Furuhashi H; Kimura A; Nishiyama K; Maejima T; Okada Y; Kurihara C; Shimamura K; Ebinuma H; Saito H; Yokoyama H; Watanabe C; Komoto S; Nagao S; Sugiyama K; Aosasa S; Hatsuse K; Yamamoto J; Hibi T; Miura S; Hokari R; Kanai T
J Hepatol; 2014 Jul; 61(1):98-106. PubMed ID: 24657401
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein Lipase Up-regulation in Hepatic Stellate Cells Exacerbates Liver Fibrosis in Nonalcoholic Steatohepatitis in Mice.
Teratani T; Tomita K; Furuhashi H; Sugihara N; Higashiyama M; Nishikawa M; Irie R; Takajo T; Wada A; Horiuchi K; Inaba K; Hanawa Y; Shibuya N; Okada Y; Kurihara C; Nishii S; Mizoguchi A; Hozumi H; Watanabe C; Komoto S; Nagao S; Yamamoto J; Miura S; Hokari R; Kanai T
Hepatol Commun; 2019 Aug; 3(8):1098-1112. PubMed ID: 31388630
[TBL] [Abstract][Full Text] [Related]
5. A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells.
Teratani T; Tomita K; Suzuki T; Oshikawa T; Yokoyama H; Shimamura K; Tominaga S; Hiroi S; Irie R; Okada Y; Kurihara C; Ebinuma H; Saito H; Hokari R; Sugiyama K; Kanai T; Miura S; Hibi T
Gastroenterology; 2012 Jan; 142(1):152-164.e10. PubMed ID: 21995947
[TBL] [Abstract][Full Text] [Related]
6. Vitamin A-coupled liposome system targeting free cholesterol accumulation in hepatic stellate cells offers a beneficial therapeutic strategy for liver fibrosis.
Furuhashi H; Tomita K; Teratani T; Shimizu M; Nishikawa M; Higashiyama M; Takajo T; Shirakabe K; Maruta K; Okada Y; Kurihara C; Watanabe C; Komoto S; Aosasa S; Nagao S; Yamamoto J; Miura S; Hokari R
Hepatol Res; 2018 Apr; 48(5):397-407. PubMed ID: 29243365
[TBL] [Abstract][Full Text] [Related]
7. Niemann-Pick Type C2 Protein Mediates Hepatic Stellate Cells Activation by Regulating Free Cholesterol Accumulation.
Twu YC; Lee TS; Lin YL; Hsu SM; Wang YH; Liao CY; Wang CK; Liang YC; Liao YJ
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27420058
[TBL] [Abstract][Full Text] [Related]
8. Metformin ameliorates activation of hepatic stellate cells and hepatic fibrosis by succinate and GPR91 inhibition.
Nguyen G; Park SY; Le CT; Park WS; Choi DH; Cho EH
Biochem Biophys Res Commun; 2018 Jan; 495(4):2649-2656. PubMed ID: 29278707
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of carnitine palmitoyltransferase 1A in hepatic stellate cells protects against fibrosis.
Fondevila MF; Fernandez U; Heras V; Parracho T; Gonzalez-Rellan MJ; Novoa E; Porteiro B; Alonso C; Mayo R; da Silva Lima N; Iglesias C; Filliol AA; Senra A; Delgado TC; Woodhoo A; Herrero L; Serra D; Prevot V; Schwaninger M; López M; Dieguez C; Millet O; Mato JM; Cubero FJ; Varela-Rey M; Iruzubieta P; Crespo J; Martinez-Chantar ML; Schwabe RF; Nogueiras R
J Hepatol; 2022 Jul; 77(1):15-28. PubMed ID: 35167910
[TBL] [Abstract][Full Text] [Related]
10. Enhanced expression of BMP6 inhibits hepatic fibrosis in non-alcoholic fatty liver disease.
Arndt S; Wacker E; Dorn C; Koch A; Saugspier M; Thasler WE; Hartmann A; Bosserhoff AK; Hellerbrand C
Gut; 2015 Jun; 64(6):973-81. PubMed ID: 25011936
[TBL] [Abstract][Full Text] [Related]
11. Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice.
Tomita K; Tamiya G; Ando S; Ohsumi K; Chiyo T; Mizutani A; Kitamura N; Toda K; Kaneko T; Horie Y; Han JY; Kato S; Shimoda M; Oike Y; Tomizawa M; Makino S; Ohkura T; Saito H; Kumagai N; Nagata H; Ishii H; Hibi T
Gut; 2006 Mar; 55(3):415-24. PubMed ID: 16174657
[TBL] [Abstract][Full Text] [Related]
12. Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease.
Dongiovanni P; Meroni M; Baselli GA; Bassani GA; Rametta R; Pietrelli A; Maggioni M; Facciotti F; Trunzo V; Badiali S; Fargion S; Gatti S; Valenti L
Clin Sci (Lond); 2017 Jun; 131(12):1301-1315. PubMed ID: 28468951
[TBL] [Abstract][Full Text] [Related]
13. Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis.
Widjaja AA; Singh BK; Adami E; Viswanathan S; Dong J; D'Agostino GA; Ng B; Lim WW; Tan J; Paleja BS; Tripathi M; Lim SY; Shekeran SG; Chothani SP; Rabes A; Sombetzki M; Bruinstroop E; Min LP; Sinha RA; Albani S; Yen PM; Schafer S; Cook SA
Gastroenterology; 2019 Sep; 157(3):777-792.e14. PubMed ID: 31078624
[TBL] [Abstract][Full Text] [Related]
14. Thrombospondin-I is a critical modulator in non-alcoholic steatohepatitis (NASH).
Min-DeBartolo J; Schlerman F; Akare S; Wang J; McMahon J; Zhan Y; Syed J; He W; Zhang B; Martinez RV
PLoS One; 2019; 14(12):e0226854. PubMed ID: 31891606
[TBL] [Abstract][Full Text] [Related]
15. Fibronectin Type III Domain-Containing 5 Attenuates Liver Fibrosis Via Inhibition of Hepatic Stellate Cell Activation.
Zhou B; Ling L; Zhang F; Liu TY; Zhou H; Qi XH; Chen Q; Li YH; Kang YM; Zhu GQ
Cell Physiol Biochem; 2018; 48(1):227-236. PubMed ID: 30007970
[TBL] [Abstract][Full Text] [Related]
16. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM
Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126
[TBL] [Abstract][Full Text] [Related]
17. Myeloperoxidase-Hepatocyte-Stellate Cell Cross Talk Promotes Hepatocyte Injury and Fibrosis in Experimental Nonalcoholic Steatohepatitis.
Pulli B; Ali M; Iwamoto Y; Zeller MW; Schob S; Linnoila JJ; Chen JW
Antioxid Redox Signal; 2015 Dec; 23(16):1255-69. PubMed ID: 26058518
[TBL] [Abstract][Full Text] [Related]
18. Elevated free cholesterol in a p62 overexpression model of non-alcoholic steatohepatitis.
Simon Y; Kessler SM; Gemperlein K; Bohle RM; Müller R; Haybaeck J; Kiemer AK
World J Gastroenterol; 2014 Dec; 20(47):17839-50. PubMed ID: 25548482
[TBL] [Abstract][Full Text] [Related]
19. Novel Interplay Between Sonic Hedgehog and Transforming Growth Factor-β1 in Human Nonalcoholic Steatohepatitis.
Zhou X; Wang P; Ma Z; Li M; Teng X; Sun L; Wan G; Li Y; Guo L; Liu H
Appl Immunohistochem Mol Morphol; 2020 Feb; 28(2):154-160. PubMed ID: 32044884
[TBL] [Abstract][Full Text] [Related]
20. Cytoglobin deficiency promotes liver cancer development from hepatosteatosis through activation of the oxidative stress pathway.
Thuy le TT; Matsumoto Y; Thuy TT; Hai H; Suoh M; Urahara Y; Motoyama H; Fujii H; Tamori A; Kubo S; Takemura S; Morita T; Yoshizato K; Kawada N
Am J Pathol; 2015 Apr; 185(4):1045-60. PubMed ID: 25665792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
